Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-03 4:41 pm Purchase | 2023-07-25 | 13D | Turnstone Biologics Corp. TSBX | Versant Venture Capital V L.P. | 2,899,216 12.500% | 2,899,216 (New Position) | Filing History |
| 2023-02-09 4:30 pm Unchanged | 2022-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Versant Venture Capital V L.P. | 2,895,695 3.500% | 0 (Unchanged) | Filing History |
| 2023-01-06 4:19 pm Sale | 2022-12-29 | 13D | Repare Therapeutics Inc. RPTX | Versant Venture Capital V L.P. | 2,094,451 5.000% | -250,000 (-10.66%) | Filing History |
| 2022-06-13 4:38 pm Sale | 2022-06-03 | 13D | Repare Therapeutics Inc. RPTX | Versant Venture Capital V L.P. | 2,344,451 5.600% | -250,000 (-9.64%) | Filing History |
| 2022-02-10 8:21 pm Sale | 2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Versant Venture Capital V L.P. | 382,961 0.800% | -1,512,041 (-79.79%) | Filing History |
| 2022-02-10 7:58 pm Unchanged | 2021-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Versant Venture Capital V L.P. | 2,895,695 4.300% | 0 (Unchanged) | Filing History |
| 2021-08-16 4:57 pm Unchanged | 2021-08-05 | 13D | Repare Therapeutics Inc. RPTX | Versant Venture Capital V L.P. | 2,594,451 7.000% | 0 (Unchanged) | Filing History |
| 2021-04-19 6:05 pm Purchase | 2021-04-08 | 13D | VectivBio Holding AG VECT | Versant Venture Capital V L.P. | 2,791,748 8.200% | 2,791,748 (New Position) | Filing History |
| 2021-02-26 4:36 pm Sale | 2021-02-16 | 13D | Repare Therapeutics Inc. RPTX | Versant Venture Capital V L.P. | 2,594,451 7.100% | -550,000 (-17.49%) | Filing History |
| 2021-02-16 07:30 am Unchanged | 2020-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Versant Venture Capital V L.P. | 2,895,695 6.100% | 0 (Unchanged) | Filing History |
| 2021-02-12 8:27 pm Sale | 2020-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Versant Venture Capital V L.P. | 1,895,002 5.800% | -789,560 (-29.41%) | Filing History |
| 2021-01-25 4:27 pm Sale | 2021-01-14 | 13D | Repare Therapeutics Inc. RPTX | Versant Venture Capital V L.P. | 3,144,451 8.600% | -275,000 (-8.04%) | Filing History |
| 2020-07-06 9:31 pm Purchase | 2020-06-23 | 13D | Repare Therapeutics Inc. RPTX | Versant Venture Capital V L.P. | 3,419,451 9.300% | 3,419,451 (New Position) | Filing History |